Clinical ischemia-reperfusion injury: Driven by reductive rather than oxidative stress? A narrative review

  • 0Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, the Netherlands.

|

|

Summary

This summary is machine-generated.

Ischemia-reperfusion (IR) injury in kidneys is driven by metabolic dysfunction, not traditional factors. This study reveals a metabolic signature of IR injury, suggesting reductive stress as a key driver.

Area Of Science

  • Nephrology
  • Transplantation Biology
  • Metabolic Medicine

Background

  • Ischemia-reperfusion (IR) injury is a significant cause of organ dysfunction after transient ischemia.
  • Preclinical therapies for IR injury often fail in clinical translation, highlighting a gap in understanding.
  • Kidney donation and transplantation serve as a relevant clinical model for studying IR injury.

Purpose Of The Study

  • To systematically investigate the mechanisms underlying clinical ischemia-reperfusion injury.
  • To identify the key molecular events driving IR injury in a clinical setting.
  • To explore potential therapeutic strategies targeting the identified mechanisms.

Main Methods

  • Utilized kidney donation and transplantation as a clinical model for IR injury.
  • Performed a systematic investigation into the molecular mechanisms of IR injury.
  • Analyzed metabolic signatures and biochemical pathways associated with IR injury.

Main Results

  • Identified a distinct metabolic signature for renal IR injury, challenging traditional culprits like reactive oxygen species, complement activation, or inflammation.
  • Observed a post-reperfusion metabolic paralysis characterized by high-energy phosphate depletion and tricarboxylic acid cycle defects.
  • Revealed compensatory activation of catabolic routes in response to metabolic dysfunction.
  • Concluded that clinical IR injury is primarily driven by reductive stress.

Conclusions

  • Clinical IR injury is characterized by a metabolic signature, not solely by inflammation or oxidative stress.
  • Reductive stress emerges as a critical factor driving IR injury in the clinical context.
  • Understanding these metabolic derangements and reductive stress is crucial for developing effective clinical therapies to restore redox balance.